Clinical Trial Update: Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating MAraViroc and/or METformin for hepatic steatosis in people living with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatic Steatosis

Drugs mentioned

• Maraviroc (maraviroc)
• metformin (metformin)

Snippet

Sponsor: University College, London | Conditions: Hepatic Steatosis, HIV-1-infection | Phase 2, Phase 3 | Status: COMPLETED